LifeMD, Inc. - 8.875% Series A (LFMDP): Financials
Trailing 12 months ended June 30, 2026
Income statement, cash flow and balance sheet figures for LifeMD, Inc. - 8.875% Series A (LFMDP), read directly from the XBRL data the company files with the SEC. Over the trailing twelve months the company reported $164.7M of revenue, up 3.8% year over year. Net income was $201.0K, or $-0.03 per diluted share. Free cash flow was -$11.1M. Gross margin stood at 86.1%.
14 fiscal years of history are available, back to 2012.
Frequently asked questions
How much revenue does LFMDP make?
LifeMD, Inc. - 8.875% Series A reported $164.7M of revenue over the trailing twelve months, for the period ended June 30, 2026. That is up 3.8% from the same period a year earlier.
Is LFMDP profitable?
LifeMD, Inc. - 8.875% Series A was profitable over the trailing twelve months, earning $201.0K of net income, a net margin of 0.1%.
Where does this financial data come from?
Every figure on this page is read from the company's own SEC 10-Q and 10-K filings. Nothing is estimated by a third party. Quarterly figures a company does not file separately (most commonly the fourth quarter) are derived by subtracting the reported year-to-date quarters from the full fiscal year, and are labelled as derived.
What is the difference between quarterly, annual and TTM?
Quarterly shows each three-month fiscal period on its own. Annual shows the full fiscal year as filed in the 10-K. TTM (trailing twelve months) sums the last four reported quarters, which is the most current annualised view between 10-K filings.